Jennifer Stamps v. Collagen Corporation

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• holding that MDA regulatory structure for a Class III device preempts inadequate labeling, defective design and manufacture claims
• holding that plaintiffs claims against the manufacturer of antiwrinkle treatment product for defective design, inadequate warnings and negligent failure to warn were preempted by the MDA
• concluding that regulation 808.1(d) poses the same test as the statute
• preempting claims for inadequate labeling, failure to warn, defective design and manufacture against manufacturer of Zyplast, a Class III device with PMA
• preempting tort claims against manufacturer of penile prosthesis, which bypassed premarket approval through 510(k
• discussing the FDA’s classification of medical devices and different requirements for each

Source: CourtListener parenthetical corpus (CC0).